Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
83 pending office actions • 39 art units • 80 examiners • 0 of 83 (0%) have an AI response strategy ready • 72 patents granted in the last 365 days
Duke University manages 83 pending office actions in the Biotechnology & Pharmaceuticals technology area. This volume of work is distributed across 80 distinct examiners, which creates a diverse examination environment. Such a broad distribution ensures that the university's overall intellectual property strategy is not dependent on a single examiner's decision.
The pending actions are spread across 40 distinct art units, indicating that the university's research covers many biotechnological and pharmaceutical sub-fields. KELLY, ROBERT M is the busiest examiner with 2 pending actions, representing a small portion of the 83 pending office actions. This suggests that the pending workload is processed independently across different departments.
For practitioners, the presence of 40 distinct art units means that prosecution strategies must be tailored to many different departmental standards. With 80 distinct examiners involved, there is little opportunity to leverage familiarity with a single examiner's style across multiple cases. The university's strategy in the Biotechnology & Pharmaceuticals sector is defined by its technical breadth and the decentralized nature of its 83 pending office actions.
Based on the USPTO statutory response window for each pending office action. 21 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 21 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 15 (18%) |
| §103 only | 21 (25%) |
| §102 only | 3 (4%) |
| §112 only | 6 (7%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 11 (13%) |
| Multi-statute (no §101) | 26 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KELLY, ROBERT M | 2 | 74.1% | +24.6% |
| REDDIG, PETER J | 2 | 57.9% | +40.2% |
| GRABER, JAMES J | 2 | 46.7% | +57.7% |
| ALBERS, KEVIN S | 1 | 26.6% | +49.7% |
| STRACHAN, KATE ELIZABETH | 1 | 48.2% | +29.2% |
| THUESON, HANNA MARIE | 1 | 76.7% | +28.2% |
| ROCHELLE, CIERRA MARIE | 1 | 100.0% | +0.0% |
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
| JACKSON, SHAWQUIA | 1 | 78.0% | -3.3% |
| FRENCH, CORRELL T | 1 | 44.4% | +32.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18925601 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | ROCHELLE, CIERRA MARIE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17265731 | Enhanced Delivery of Drugs and Other Compounds to the Brain and Other Tissues | DONOGHUE, BRITTNEY ERIN | 23d overdue |
| 18962035 | NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE | ALBERS, KEVIN S | 14d |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | GRABER, JAMES J | 15d |
| 18867588 | SYSTEMS AND METHODS FOR CALCULATING VOLUMES OF EXCRETED URINE AND STOOL | STRACHAN, KATE ELIZABETH | — |
| 18862323 | PATIENT-DERIVED CELL-CONTAINING DROPLETS ENABLE CLINICAL PRECISION ONCOLOGY | THUESON, HANNA MARIE | — |
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | KELLY, ROBERT M | — |
| 18893942 | KNEE IMPLANT | JANOSKO, CHASITY PAIGE | — |
| 18849279 | COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY | JACKSON, SHAWQUIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18962035 | NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE | ALBERS, KEVIN S | 14d |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | GRABER, JAMES J | 15d |
| 18867588 | SYSTEMS AND METHODS FOR CALCULATING VOLUMES OF EXCRETED URINE AND STOOL | STRACHAN, KATE ELIZABETH | — |
| 18862323 | PATIENT-DERIVED CELL-CONTAINING DROPLETS ENABLE CLINICAL PRECISION ONCOLOGY | THUESON, HANNA MARIE | — |
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | KELLY, ROBERT M | — |
| 18893942 | KNEE IMPLANT | JANOSKO, CHASITY PAIGE | — |
| 18759804 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR EARLY DETECTION OF A NEURODEVELOPMENTAL OR PSYCHIATRIC DISORDER USING SCALABLE COMPUTATIONAL BEHAVIORAL PHENOTYPING AND AUTOMATED MOTOR SKILLS ASSESSMENT | FRENCH, CORRELL T | — |
| 18545176 | Combination Treatment | KELLY, ROBERT M | — |
| Art Unit | Apps |
|---|---|
| 1636 | 4 |
| 1663 | 3 |
| 1675 | 3 |
| 1672 | 3 |
| 1632 | 3 |
| 1637 | 3 |
| 1631 | 3 |
| 1638 | 3 |
| 1643 | 2 |
| 1635 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18962035 | NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE | ALBERS, KEVIN S | 3786 | §103 | Final Rejection | 14d | Pending | Nov 27, 2024 |
| 18867588 | SYSTEMS AND METHODS FOR CALCULATING VOLUMES OF EXCRETED URINE AND STOOL | STRACHAN, KATE ELIZABETH | — | §102§103 | Non-Final OA | — | Pending | Nov 20, 2024 |
| 18862323 | PATIENT-DERIVED CELL-CONTAINING DROPLETS ENABLE CLINICAL PRECISION ONCOLOGY | THUESON, HANNA MARIE | — | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | KELLY, ROBERT M | — | §103§112 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18925601 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | ROCHELLE, CIERRA MARIE | — | §103§112DP | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18893942 | KNEE IMPLANT | JANOSKO, CHASITY PAIGE | — | §103§112 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18849279 | COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY | JACKSON, SHAWQUIA | — | §102§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18759804 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR EARLY DETECTION OF A NEURODEVELOPMENTAL OR PSYCHIATRIC DISORDER USING SCALABLE COMPUTATIONAL BEHAVIORAL PHENOTYPING AND AUTOMATED MOTOR SKILLS ASSESSMENT | FRENCH, CORRELL T | 3715 | §101§102§103 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18744161 | COMPOSITIONS AND METHODS OF TREATING INVASIVE PATHOGENS | TRAN, ERIC | — | §102§103§112 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18713948 | METALLIC SINGLE-WALLED CARBON NANOTUBE HYBRID ASSEMBLIES AND SUPERSTRUCTURES | THOMPSON, CAMIE S | 1786 | §103 | Non-Final OA | — | Pending | May 28, 2024 |
| 18668784 | METHOD AND SYSTEM FOR NOISE CANCELLATION BASED ON QUBIT FEEDBACK | EBERSMAN, BRUCE I | — | §103 | Non-Final OA | — | Pending | May 20, 2024 |
| 18707971 | Compositions and Methods for Modulating the Effect of Beta-Blocker Activity in a Subject | MOU, LIYUAN | — | §103§112 | Non-Final OA | — | Pending | May 07, 2024 |
| 18652899 | NPR1 VARIANT TO ENHANCE PLANT RESISTANCE TO BIOTIC AND ABIOTIC STRESSES AND METHOD THEREOF | ORDAZ, CHRISTIAN JOSE | 1663 | §112 | Final Rejection | — | Pending | May 02, 2024 |
| 18649219 | MACHINE LEARNING AIDED REALISM-ENHANCED VIRTUAL CLINICAL IMAGING WITH GROUND TRUTH PRESERVATION | TRAN, JENNY NGAN | 2615 | §101§103 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18703125 | COMPOSITIONS AND METHODS FOR TARGETING GPCR FOR THE PREVENTION AND TREATMENT OF PAIN | GONZALEZ, LUISALBERTO | — | §102§103§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18633760 | METHODS FOR REDUCING ISCHEMIA-REPERFUSION INJURIES | ROZOF, TIMOTHY R | 1625 | §102 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18700677 | COMPOSITIONS COMPRISING HIV ENVELOPES TO INDUCE HIV-1 ANTIBODIES | FOLEY, SHANON A | — | §101§102§112DP | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18629315 | SYSTEMS AND METHODS FOR SEEDLESS FRUIT TRAIT | CHATTERJEE, JAYANTA | 1662 | §102§112 | Final Rejection | — | Pending | Apr 08, 2024 |
| 18629894 | LASOFOXIFENE TREATMENT OF BREAST CANCER | PECKHAM, RICHARD GRANT | — | §101§103§112 | Non-Final OA | — | Pending | Apr 08, 2024 |
| 18626187 | ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | CHENG, KAREN | — | §102§103 | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18697976 | COMPOSITIONS COMPRISING SMALL MOLECULE REGULATORS OF TUMOR IMMUNITY AND METHODS OF USING SAME | WILSON, JERICA KATLYNN | 1621 | §103§112 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18611203 | Systems and Methods for the Direct Comparison of Molecular Derivatives | ACOSTA, RILEY SULLIVAN | — | §101§102§103 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18581157 | COMPUTATIONAL IMAGE CONTRAST FROM MULTI-DIMENSIONAL DATA | BUDISALICH, ANDREW STEVEN | 2662 | §103 | Final Rejection | — | Pending | Feb 19, 2024 |
| 18684346 | NEXT GENERATION VACCINES COMPRISING ANTIGENIC LIBRARIES AND METHODS OF MAKING AND USING SAME | GILL, RACHEL B | 1671 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18683650 | NON-IMMUNOGENIC, HIGH DENSITY POEGMA CONJUGATES | CESARE, JOSEPH DAVID | — | §102§103 | Non-Final OA | — | Pending | Feb 14, 2024 |
| 18578262 | VOLUME REDUCTION SOLIDS TREATMENT SYSTEM | GURTOWSKI, RICHARD C | 1773 | §103 | Final Rejection | 49d | Pending | Jan 10, 2024 |
| 18575098 | RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT | MOSHER, ERIC PARKER | — | §102§103§112 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18392091 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PATHOLOGICAL FIBROBLAST CELLS | MELCHIOR, JAMES RYLAND | — | §101§102§103§112DP | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18545176 | Combination Treatment | KELLY, ROBERT M | — | §112Other | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18570967 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEMOGLOBINOPATHIES | YU, DELPHINUS DOU YI | — | §103§112DP | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18532709 | COMPLEMENT FACTOR H ANTIBODIES | SZPERKA, MICHAEL EDWARD | — | §101§102§112DP | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18513095 | TARGETED INHIBITION OF DKK3 TO SENSITIZE TUMORS TO IMMUNOTHERAPY | STOICA, ELLY GERALD | — | §102§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18511825 | RECOMBINANT TIM-4 PROTEIN, CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL DELIVERY SYSTEM AND METHODS OF MAKING AND USING SAME | BORGEEST, CHRISTINA M | 1675 | §103 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18511817 | CHIMERIC APOPTOTIC SIGNAL TARGETING LYMPHOCYTES (TIM-4 CASTL) AND METHODS OF MAKING AND USING SAME | REDDIG, PETER J | — | §102§103§112DP | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18499880 | METHODS FOR DETECTING ONCOGENIC KRAS MUTATIONS | BELLAH, JEFFREY LAWRENCE | 1683 | §103§112 | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18557787 | ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME | JADHAO, SAMADHAN JAISING | 1672 | §101§103 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18288505 | COMPOSITIONS AND METHODS FOR RAPID GENERATION OF MODIFIABLE STABLE CELL LINES | BEHARRY, ZANNA MARIA | 1632 | §103§112DP | Final Rejection | 63d | Pending | Oct 26, 2023 |
| 18486146 | M6A-COUPLED EFFECTOR PROTEIN EXPRESSION SYSTEM AND METHODS OF MAKING AND USING SAME | ALLEN, SARAH ELIZABETH | 1637 | §101§112DP | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18376919 | REGIONAL MOTION DISPLAY AND ASSESSMENT IMAGING | TRAN, DUY ANH | 2674 | §103 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18553703 | METHODS FOR DETERMINING TUMOR IMMUNE STATUS | NICKOL, GARY B | 1643 | §101§103 | Non-Final OA | — | Pending | Oct 02, 2023 |
| 18552693 | Compositions For and Methods of Editing the Genome | MONTANARI, DAVID A | 1632 | §102 | Non-Final OA | — | Pending | Sep 27, 2023 |
| 18551547 | COMPOSITIONS AND METHODS FOR RAPID COVID-19 DETECTION | CHEN, STACY BROWN | 1672 | §102§103§112 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18550928 | GENERATION OF NOVEL CRISPR GENOME EDITING AGENTS USING COMBINATORIAL CHEMISTRY | OLSON, ALEXANDRA NADINE | — | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18547332 | Compositions For and Methods of Improving Gene Therapy | GRABER, JAMES J | 1631 | §102§103 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18271983 | COMPOSITIONS AND METHODS FOR THE GENETIC MANIPULATION OF THE INFLUENZA VIRUS | GRIZER, CASSANDRA SENN | 1672 | §103 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18269622 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103§112 | Non-Final OA | — | Pending | Jun 26, 2023 |
| 18036862 | TARGETED GENE REGULATION OF HUMAN IMMUNE CELLS WITH CRISPR-CAS SYSTEMS | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Non-Final OA | — | Pending | May 12, 2023 |
| 18036721 | TOUGH, REPROCESSABLE ELASTOMERS AND METHODS OF MAKING AND USING SAME | KARST, DAVID THOMAS | 1767 | §103 | Non-Final OA | — | Pending | May 12, 2023 |
| 18312719 | SYSTEMS AND METHODS FOR PROMOTING REMYELINATION WITH FACTORS DERIVED FROM UMBILICAL CORD BLOOD MACROPHAGES | DENT, ALANA HARRIS | 1643 | §102§103DP | Final Rejection | 20d | Pending | May 05, 2023 |
| 18033049 | DUAL AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | ARIETI, RUTH SOPHIA | 1635 | §101§102§103§112DP | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18030745 | NOVEL TARGETS FOR REACTIVATION OF PRADER-WILLI SYNDROME-ASSOCIATED GENES | HUDSON, AMY ROSE | 1636 | §102§103§112 | Non-Final OA | — | Pending | Apr 06, 2023 |
| 18180718 | SYSTEMS AND METHODS FOR GENOME-WIDE ANNOTATION OF GENE REGULATORY ELEMENTS LINKED TO CELL FITNESS | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103 | Final Rejection | — | Pending | Mar 08, 2023 |
| 18173358 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH | SCHWECHTER, BRANDON ROSS | 1674 | §102§103 | Non-Final OA | — | Pending | Feb 23, 2023 |
| 18042032 | MICROFLUIDIC ASSAY DEVICE | GIERE, REBECCA M | 1677 | §103§112 | Non-Final OA | — | Pending | Feb 17, 2023 |
| 18107942 | CROSSTALK SUPPRESSION WITH LOCAL CONTROLS | STOFFA, WYATT A | 2881 | §112 | Non-Final OA | 125d overdue | Pending | Feb 09, 2023 |
| 18099631 | SUSTAINABLE CONTINUAL LEARNING WITH DETECTION AND KNOWLEDGE REPURPOSING OF SIMILAR TASKS | NGUYEN, HENRY K | 2121 | §101§103§112 | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18001884 | ENHANCED CELL SURVIVAL AGAINST BIOTIC AND ABIOTIC STRESSES THROUGH SALICYLICK ACID-INDUCED NPR1 CONDENSATES | MCWILLIAMS, KELSEY LYNN | 1663 | §112 | Non-Final OA | 72d | Pending | Dec 15, 2022 |
| 18080868 | ENDOSCOPIC IMAGING AND PATTERNED STIMULATION AT CELLULAR RESOLUTION | FERNANDEZ, KATHERINE L | 3798 | §103 | Final Rejection | 16d | Pending | Dec 14, 2022 |
| 17921338 | TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1) | BRETZ, COREY LANE | 1635 | §103 | Final Rejection | 3d overdue | Pending | Oct 25, 2022 |
| 17914598 | BETA-ARRESTIN COMPOSITIONS AND ASSOCIATED METHODS | MACFARLANE, STACEY NEE | 1675 | §102 | Final Rejection | 26d | Pending | Sep 26, 2022 |
| 17912429 | COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER | MOORE, SUSANNA | 1624 | §103 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17906372 | METHODS AND COMPOSITIONS FOR IMPROVED TYPE I-E CRISPR BASED GENE SILENCING | HASAN, KHALEDA B | 1636 | §102§103DP | Non-Final OA | — | Pending | Sep 15, 2022 |
| 17908415 | PROTEIN NANOPARTICLE DESIGN AND APPLICATION | CARTER, SANDRA DILLAHUNT | 1674 | §112 | Final Rejection | 92d overdue | Pending | Aug 31, 2022 |
| 17908427 | PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION | TSAY, MARSHA M | 1656 | §103§112DP | Final Rejection | — | Pending | Aug 31, 2022 |
| 17819100 | Dynamic control over multiple host proteases in a genetically modifiel microorganism | RAMIREZ, DELIA M | 1652 | §103 | Non-Final OA | 55d | Pending | Aug 11, 2022 |
| 17758480 | COMPOSISTIONS AND METHODS FOR CRISPR ENABLED DNA SYNTHESIS | ZARA, JANE J | 1637 | §112 | Non-Final OA | 88d overdue | Pending | Jul 07, 2022 |
| 17840310 | METHODS FOR TREATING PAIN | JOHNSON, ALLISON MARIE | 1638 | §103 | Non-Final OA | — | Pending | Jun 14, 2022 |
| 17782559 | Pudendal Nerve Burst Stimulation for Bladder Control | HADDAD, MOUSSA MAHER | 3796 | §103§112DP | Non-Final OA | 52d overdue | Pending | Jun 03, 2022 |
| 17782112 | SYSTEMS AND METHODS FOR LIPID NANOPARTICLE DELIVERY OF GENE EDITING MACHINERY | YU, DAVID TUYANG | 1600 | §102§103 | Final Rejection | — | Pending | Jun 02, 2022 |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | GRABER, JAMES J | 1631 | §103§112 | Final Rejection | 15d | Pending | Feb 23, 2022 |
| 17636750 | COMPOSITIONS AND METHODS FOR IDENTIFYING REGULATORS OF CELL TYPE FATE SPECIFICATION | REGA, KYLE THOMAS | 1636 | §102§103§112DP | Non-Final OA | 9d | Pending | Feb 18, 2022 |
| 17674212 | SYSTEMS AND METHODS FOR NERVE FIBER CONDUCTION BLOCK | LEE, DAVINA EN-YIN | 3794 | §103 | Final Rejection | — | Pending | Feb 17, 2022 |
| 17603329 | CRISPR/CAS-BASED GENOME EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION | EBBINGHAUS, BRIANA NOEL | 1632 | DP | Final Rejection | 52d overdue | Pending | Oct 12, 2021 |
| 17494047 | COMPOSITIONS AND METHODS FOR RAPID AND DYNAMIC FLUX CONTROL USING SYNTHETIC METABOLIC VALVES | ZAHORIK, AMANDA MARY | 1636 | §103Other | Non-Final OA | 21d | Pending | Oct 05, 2021 |
| 17328953 | VACCINES AGAINST ANTIGENS INVOLVED IN THERAPY RESISTANCE AND METHODS OF USING SAME | REDDIG, PETER J | 1646 | §103 | Non-Final OA | — | Pending | May 24, 2021 |
| 17294368 | LIQUIDLY INJECTABLE, SELF-STABILIZING BIOPOLYMERS FOR THE DELIVERY OF RADIONUCLIDE | VU, JAKE MINH | 1618 | §103§112 | Non-Final OA | — | Pending | May 14, 2021 |
| 17265731 | Enhanced Delivery of Drugs and Other Compounds to the Brain and Other Tissues | DONOGHUE, BRITTNEY ERIN | 1675 | §103§112Other | Non-Final OA | 23d overdue | Pending | Feb 03, 2021 |
| 17162601 | FAULT CRITICALITY ASSESSMENT USING GRAPH CONVOLUTIONAL NETWORKS | FACCENDA, GISEL GABRIELA | 2127 | §101§103§112 | Final Rejection | — | Pending | Jan 29, 2021 |
| 17260094 | BRAIN INJURY MONITORING WITH RECOVERY TRAJECTORY | TAPIA, ANDREW KYLE | 3687 | §101§103 | Non-Final OA | — | Pending | Jan 13, 2021 |
| 17007994 | CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE | MEJIAS, SAMANTHA LEE | 1618 | §103Other | Final Rejection | 71d overdue | Pending | Aug 31, 2020 |
| 16632226 | COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION | STEELE, AMBER D | 1658 | §103§112DP | Non-Final OA | 4d overdue | Pending | Jan 17, 2020 |
| 16482941 | COMPOSITIONS AND METHODS FOR CONTROLLING GENE EXPRESSION | BOGGS, RUSSELL T | 1663 | §103 | Final Rejection | 19d overdue | Pending | Aug 01, 2019 |
| 16477110 | Methods of Treating Brain Injury Using Cord Blood or a Component Thereof | WILSON, MICHAEL C | 1638 | §103 | Final Rejection | — | Pending | Jul 10, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial